Search research articles
Contact Us
Filters
Showing results (511-520 of 568) with videos related to
Page
of 57
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
Therapeutic Advances in Gastroenterology
|
February 24, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry
Lucía Madero-Velázquez, Ruth de Francisco, Belen Herreros, et al.
Helicobacter
|
March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)
Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Revista Espanola De Enfermedades Digestivas
|
November 17, 2025
The implementation of PCR-guided therapy in the eradication of Helicobacter pylori: experience from the European Registry on H. pylori management (Hp-EuReg)
Vladimir Milivojevic, Dusan Kekic, Sabir Sagdati, et al.
The American Journal of Gastroenterology
|
February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)
Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2026
Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuReg
Samuel J Martínez-Domínguez, Ángel Lanas, Enrique Ceamanos, et al.
Gut
|
October 26, 2024
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection between 2013 and 2021: results from the European registry on <i>H. pylori</i> management (Hp-EuReg)
Llum Olmedo, Xavier Calvet, Emili Gené, et al.
Alimentary Pharmacology & Therapeutics
|
October 4, 2018
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
María Chaparro, Ana Garre, Elena Ricart, et al.
Alimentary Pharmacology & Therapeutics
|
April 24, 2023
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study
María José Casanova, Óscar Nantes, Pilar Varela, et al.
Helicobacter
|
July 13, 2024
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)
Samuel J Martínez-Domínguez, Olga P Nyssen, Ángel Lanas, et al.
Page
of 57
Search research articles
Search
Showing results (511-520 of 568) with videos related to
Sort By:
Page
of 57
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
Therapeutic Advances in Gastroenterology
|
February 24, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry
Lucía Madero-Velázquez, Ruth de Francisco, Belen Herreros, et al.
Helicobacter
|
March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)
Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
Revista Espanola De Enfermedades Digestivas
|
November 17, 2025
The implementation of PCR-guided therapy in the eradication of Helicobacter pylori: experience from the European Registry on H. pylori management (Hp-EuReg)
Vladimir Milivojevic, Dusan Kekic, Sabir Sagdati, et al.
The American Journal of Gastroenterology
|
February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)
Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2026
Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuReg
Samuel J Martínez-Domínguez, Ángel Lanas, Enrique Ceamanos, et al.
Gut
|
October 26, 2024
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection between 2013 and 2021: results from the European registry on <i>H. pylori</i> management (Hp-EuReg)
Llum Olmedo, Xavier Calvet, Emili Gené, et al.
Alimentary Pharmacology & Therapeutics
|
October 4, 2018
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
María Chaparro, Ana Garre, Elena Ricart, et al.
Alimentary Pharmacology & Therapeutics
|
April 24, 2023
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study
María José Casanova, Óscar Nantes, Pilar Varela, et al.
Helicobacter
|
July 13, 2024
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)
Samuel J Martínez-Domínguez, Olga P Nyssen, Ángel Lanas, et al.
Page
of 57